Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Warren Buffett And CalSTRS Agree On Brian Moynihan's Performance At Bank Of America also written by Antoine Gara
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
Login to comment.